AGENTS THERAPEUTIQUES CONTRE L'ACHONDROPLASIE

• 收藏
• 分享

专利权人:

NAKAO; KAZUWA

发明人:

NAKAO, KAZUWA

申请号：

CA2398030

公开号：

CA2398030C

申请日:

2002.08.14

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

The present invention aims to provide novel therapeutic agents for achondroplasia caused by mutations in FGFR3. Therapeutic agents for achondroplasia caused by the cartilage growth inhibition resulting from mutations in the gene for fibroblast growth factor receptor 3 (FGFR3), comprising a substance activating guanylyl cyclase B (GC-B) as an active ingredient are disclosed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/